Cross-resistance to intercalating agents in an epipodophyllotoxin-resistant Chinese hamster ovary cell line: evidence for a common intracellular target.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Cancer Research

• Publication date

  1986-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 3004712
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of acquired epipodophyllotoxin resistance in a Chinese hamster ovary cell line: loss of drug-stimulated DNA cleavage activity.

  1986cited by this paper
• Verapamil-induced augmentation of etoposide accumulation in L1210 cells in vitro.

  1985cited by this paper
• In vivo mapping of DNA topoisomerase II-specific cleavage sites on SV40 chromatin.

  1985cited by this paper
• Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage.

  1984cited by this paper
• Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide.

  1984cited by this paper
• DNA topoisomerase II mutant of Saccharomyces cerevisiae: topoisomerase II is required for segregation of daughter molecules at the termination of DNA replication.

  1984cited by this paper
• Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II.

  1984cited by this paper
• Chromatin assembly in Xenopus oocytes: in vivo studies.

  1984cited by this paper
• Rapid incorporation of label from ribonucleoside disphosphates into DNA by a cell-free high molecular weight fraction from animal cell nuclei.

  1983cited by this paper
• Cleavage of DNA by mammalian DNA topoisomerase II.

  1983cited by this paper
• Reconstitution of intercalator-induced DNA scission by an active component from nuclear extracts.

  1983cited by this paper
• Genetic, biochemical, and cross-resistance studies with mutants of Chinese hamster ovary cells resistant to the anticancer drugs, VM-26 and VP16-213.

  1983cited by this paper
• DNA double-stranded breaks in mammalian cells after exposure to intercalating agents.

  1981cited by this paper
• Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino) methanesulfon-m-anisidide and adriamycin.

  1981cited by this paper
• Qualitative and quantitative aspects of intercalator-induced DNA strand breaks.

  1979cited by this paper
• Fractionation of DNA from mammalian cells by alkaline elution.

  1976cited by this paper

• Topoisomerases and cancer chemotherapy: recent advances and unanswered questions

  2019cites this paper
• Cancer Stem Cells and Multi-drug Resistance by Flow Cytometry

  2017cites this paper
• Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells

  2012cites this paper
• Structural and functional properties of human multidrug resistance protein 1 (MRP1/ABCC1).

  2011cites this paper
• The pathogenesis of cancer metastasis: Relevance to therapy

  2009cites this paper
• Ability of four potential topoisomerase II inhibitors to enhance the cytotoxicity ofcis-diamminedichloroplatinum (II) in Chinese hamster ovary cells and in an epipodophyllotoxin-resistant subline

  2008cites this paper
• Cell Lines Mechanisms of Doxorubicin Resistance in Two Human Tumor Pharmacological and Biological Evidence for Differing Updated

  2006cites this paper
• Topoisomerase Il-dependent and -independent Mechanisms of Etoposide Resistance in Chinese Hamster Cell Lines1

  2006cites this paper
• Leukemia Cell Lines Cytotoxicity in Adriamycin-sensitive and-resistant P 388 Direct Correlation between DNA Topoisomerase II Activity and Updated Version

  2006cites this paper
• Resistance in Human Gastric Carcinoma Cell Line EPG 85-257 Membrane Vesicle Formation Due to Acquired Mitoxantrone Updated

  2006cites this paper
• Etoposide-resistant Mutants of Human Cancer KB Cells Increased Phosphorylation of DNA Topoisomerase II in Updated

  2006cites this paper
• Evidence for a Mutant AlÃ-eleof the Gene for DNA Topoisomerase II in Adriamycin-resistant P 388 Murine Leukemia Cells 1

  2006cites this paper
• DNA-intercalators — the anthracyclines

  2006cites this paper
• Implications for the Mechanism of Action Sensitive and Resistant Human Breast Tumor Cells : DNA Strand Breaks Produced by Etoposide ( VP-16 , 213 ) in Updated

  2006cites this paper
• Plateau-Phase Chinese Hamster Fibroblast Cell Cultures Uptake , Metabolism , and DNA Breakage in Log-and-anisidide : Comparison of m-( 9-Acridinylamino ) methanesulfon-′ Mechanism of Resistance of Noncycling Mammalian Cells to 4 Updated

  2006cites this paper
• Evasion of P-gp mediated cellular efflux and permeability enhancement of HIV-protease inhibitor saquinavir by prodrug modification.

  2005cites this paper
• Expressions of resistance and cross-resistance in teniposide-resistant L1210 cells

  2004cites this paper
• Chemomodulation of drugs involved in multidrug resistance in chronic lymphatic leukemia of the B-cell type

  2004cites this paper
• Dissociation of cytotoxicity and DNA cleavage activity induced by topoisomerase II-reactive intercalating agents in hamster-human somatic cell hybrids

  2004cites this paper
• Circumventing P-glycoprotein-mediated cellular efflux of quinidine by prodrug derivatization.

  2004cites this paper
• Resistance to cytostatic drugs at the cellular level

  2004cites this paper
• P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement.

  2003cites this paper
• Altered topoisomerase IIalpha and multidrug resistance-associated protein levels during drug selection: adaptations to increasing drug pressure.

  2001cites this paper
• Behavior of Murine Renal Carcinoma Cells Grown in Ectopic or Orthotopic Sites in Syngeneic Mice

  2001cites this paper
• Aryltetralin lignans: chemistry, pharmacology and biotransformations.

  2001cites this paper
• Investigation of multidrug resistance and invasion in human cancer cell lines

  1999cites this paper
• Multidrug resistance in breast and bladder cancer cell lines

  1998cites this paper
• Idarubicin monotherapy in multiply pretreated leukemia patients: response in relation to P-glycoprotein expression

  1997cites this paper
• Preclinical Models for High-Dose Therapy

  1997cites this paper
• Differential actions of aclarubicin and doxorubicin: the role of topoisomerase I.

  1997cites this paper
• Oncogenic transformation potentiates apoptosis, S-phase arrest and stress-kinase activation by etoposide

  1997cites this paper
• Anthracyclines in haematology: preclinical studies, toxicity and delivery systems.

  1997cites this paper
• Cellular adaptation to drug exposure: evolution of the drug-resistant phenotype.

  1997cites this paper
• Clinical multidrug resistance in cancer: a multifactorial problem.

  1996cites this paper
• DNA Topoisomerase II Poisons and the Cell Cycle

  1996cites this paper
• Etoposide: twenty years later.

  1995cites this paper
• Topoisomerases in Multidrug Resistance

  1995cites this paper
• Multidrug Resistance‐associated Protein‐mediated Multidrug Resistance Modulated by Cyclosporin A in a Human Bladder Cancer Cell Line

  1995cites this paper
• In vitro models of multiple drug resistance.

  1994cites this paper
• Reversal of Multidrug Resistance by R-Verapamil

  1994cites this paper
• Anthracycline Antibiotics in Cancer Therapy

  1994cites this paper
• Modulation of tumor cell response to chemotherapy by the organ environment

  1994cites this paper
• Cellular regulation of mammalian DNA topoisomerases.

  1994cites this paper
• Retrovirus-mediated gene transfer of rat glutathione S-transferase Yc confers alkylating drug resistance in NIH 3T3 mouse fibroblasts.

  1994cites this paper
• Anthracycline antibiotics in cancer therapy. Focus on drug resistance.

  1994cites this paper
• Mechanistic studies of amsacrine-resistant derivatives of DNA topoisomerase II. Implications in resistance to multiple antitumor drugs targeting the enzyme.

  1994cites this paper
• Differential sensitivity patterns in small cell lung cancer cell lines: detection and circumvention of resistance to topoisomerase II targeting drugs.

  1994cites this paper
• Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance.

  1994cites this paper
• Different modes of anthracycline interaction with topoisomerase II. Separate structures critical for DNA-cleavage, and for overcoming topoisomerase II-related drug resistance.

  1993cites this paper
• Protracted drug infusions in cancer treatment: an appraisal of 5-fluorouracil, doxorubicin, and platinums.

  1993cites this paper
• The induction and reversal of topoisomerase II cleavable complexes formed by nuclear extract from the CHO DNA repair mutant, xrs1.

  1993cites this paper
• Conditional expression of wild-type topoisomerase II complements a mutant enzyme in mammalian cells.

  1993cites this paper
• Multifactorial resistance to antineoplastic agents in drug-resistant P388 murine leukemia, Chinese hamster ovary, and human HeLa cells, with emphasis on the role of DNA topoisomerase II.

  1992cites this paper
• Intercalation of anthracyclines into living cell DNA analyzed by flow cytometry.

  1992cites this paper
• An overview of membrane, cytosolic and nuclear proteins associated with the expression of resistance to multiple drugs in vitro.

  1992cites this paper
• Antitumor agents, 130, Novel 4 beta-arylamino derivatives of 3',4'-didemethoxy-3',4'-dioxo-4-deoxypodophyllotoxin as potent inhibitors of human DNA topoisomerase II.

  1992cites this paper
• Amplification of the topoisomerase II alpha gene in a non-small cell lung cancer cell line and characterisation of polymorphisms at the human topoisomerase II alpha and beta loci in normal tissue.

  1992cites this paper
• Amplification of the topoisomerase ii α gene in a non‐small cell lung cancer cell line and characterisation of polymorphisms at the human topoisomerase ii α and β loci in normal tissue

  1992cites this paper
• High cell density-dependent resistance and P-glycoprotein-mediated multidrug resistance in mitoxantrone-selected Chinese hamster cells.

  1992cites this paper
• Trifluoperazine modulation of resistance to the topoisomerase II inhibitor etoposide in doxorubicin resistant L1210 murine leukemia cells.

  1991cites this paper
• Decreased DNA topoisomerase II in daunorubicin-resistant Ehrlich ascites tumor cells.

  1991cites this paper
• Modulation of the antioxidant activities in dox-sensitive and -resistant Friend leukemia cells. Effect of doxorubicin.

  1991cites this paper
• Increased phosphorylation of DNA topoisomerase II in etoposide-resistant mutants of human cancer KB cells.

  1991cites this paper
• Increased survival after treatments with anticancer agents of Chinese hamster cells expressing the human Mr 27,000 heat shock protein.

  1991cites this paper
• Antagonistic effect of aclarubicin on daunorubicin-induced cytotoxicity in human small cell lung cancer cells: relationship to DNA integrity and topoisomerase II.

  1991cites this paper
• Antioxidant defenses in a B16 melanoma line resistant to doxorubicin: an in vivo study

  1991cites this paper
• Multi-drug resistance genes in the management of neoplastic disease.

  1991cites this paper
• Etoposide with lonidamine or pentoxifylline as modulators of alkylating agent activity in vivo

  1991cites this paper
• Biochemical pharmacology of anthracenediones and anthrapyrazoles.

  1991cites this paper
• Detoxification mechanisms and tumor cell resistance to anticancer drugs.

  1991cites this paper
• Resistance to inhibitors of DNA topoisomerases.

  1991cites this paper
• Development of Multidrug Resistance in Rodent Cell Lines

  1991cites this paper
• DNA double-strand break repair pathways and cellular tolerance to inhibitors of topoisomerase II.

  1990cites this paper
• Reduction of drug accumulation and DNA topoisomerase II activity in acquired teniposide-resistant human cancer KB cell lines.

  1990cites this paper
• Antagonistic effect of aclarubicin on the cytotoxicity of etoposide and 4'-(9-acridinylamino)methanesulfon-m-anisidide in human small cell lung cancer cell lines and on topoisomerase II-mediated DNA cleavage.

  1990cites this paper
• DNA topoisomerase II as the primary target of anti-tumor anthracyclines.

  1990cites this paper
• Membrane vesicle formation due to acquired mitoxantrone resistance in human gastric carcinoma cell line EPG85-257.

  1990cites this paper
• Drug-induced DNA damage and tumor chemosensitivity.

  1990cites this paper
• Isolation and characterization of VP-16 resistant human leukemia cell line.

  1990cites this paper
• HT1080/DR4: a P-glycoprotein-negative human fibrosarcoma cell line exhibiting resistance to topoisomerase II-reactive drugs despite the presence of a drug-sensitive topoisomerase II.

  1990cites this paper
• Topoisomerases, New Targets in Cancer Chemotherapy

  1990cites this paper
• Implication of prior treatment with drug combinations including inhibitors of topoisomerase II in therapy‐related monocytic leukemia with a 9;11 translocation

  1990cites this paper
• Drug resistance and the problem of treatment failure

  1990cites this paper
• Non-P-glycoprotein-mediated multidrug resistance with reduced EGF receptor expression in a human large cell lung cancer cell line.

  1990cites this paper
• Multidrug Resistance in Leukaemia.

  1990cites this paper
• Tests for the genotoxicity of m-AMSA, etoposide, teniposide and ellipticine in Neurospora crassa.

  1990cites this paper
• Mechanisms of multidrug resistance in human tumor cells. The roles of P-glycoprotein, DNA topoisomerase II, and other factors.

  1990cites this paper
• Enhancement of murine tumor cell sensitivity to adriamycin by presentation of the drug in phosphatidylcholine-phosphatidylserine liposomes.

  1990cites this paper
• Structural characteristics of compounds that modulate P-glycoprotein-associated multidrug resistance.

  1990cites this paper
• Radiation response of drug-resistant variants of a human breast cancer cell line: the effect of glutathione depletion.

  1990cites this paper
• Multidrug resistance: focus in hematology.

  1990cites this paper
• Morphologic alterations in drug sensitive vs. drug resistant cells due to cytostatic application.

  1990cites this paper
• DNA topoisomerases as anticancer drug targets.

  1990cites this paper
• Establishment of an etoposide (VP-16)-resistant subline of THP-1 human monocytic leukemia cell line.

  1989cites this paper
• Adriamycin‐induced DNA strand breaks in HeLa and in P388 leukaemia cells detected using in situ nick translation

  1989cites this paper
• Chemoprotection by 9-aminoacridine derivatives against the cytotoxicity of topoisomerase II-directed drugs.

  1989cites this paper
• Modulation of 4'-(9-acridinylamino)methanesulfon-m-anisidide-induced, topoisomerase II-mediated DNA cleavage by gossypol.

  1989cites this paper
• Direct correlation between DNA topoisomerase II activity and cytotoxicity in adriamycin-sensitive and -resistant P388 leukemia cell lines.

  1989cites this paper
• Evidence for a mutant allele of the gene for DNA topoisomerase II in adriamycin-resistant P388 murine leukemia cells.

  1989cites this paper
• Alkaloids Independent of P-Glycoprotein Vinca Resistance to Drug-resistant Human Leukemia Cell Line ( LALW-2 ) : Atypical Multidrug Resistance in a Therapy-induced Updated

  1989cites this paper